Cargando…
Marked Efficacy of a Therapeutic Strategy in a Patient With Necrotizing Myopathy Associated With Anti-signal Recognition Particle (SRP) Autoantibodies
Necrotizing autoimmune myopathy (NAM) is a rare muscular disorder characterized by severe proximal muscle weakness. Risk factors include statin use, malignancy, and connective tissue diseases. The current study presents the first case of NAM in Saudi Arabia in a 26-year-old female who presented with...
Autores principales: | Almaghrabi, Murouj, Almatrafi, Shahad B, Alzahrani, Asma, Alharbi, Mohammed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043635/ https://www.ncbi.nlm.nih.gov/pubmed/36999097 http://dx.doi.org/10.7759/cureus.35471 |
Ejemplares similares
-
Anti-signal Recognition Particle Necrotizing Autoimmune Myopathy: An Atypical Presentation
por: Khan, Muhammad H, et al.
Publicado: (2018) -
Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies
por: Ma, Xue, et al.
Publicado: (2021) -
Anti-SRP immune-mediated necrotizing myopathy: A critical review of current concepts
por: Ma, Xue, et al.
Publicado: (2022) -
A Rare Case of Anti-HMGCR and Anti-SRP-Positive Immune-Mediated Necrotizing Myopathy
por: Khan, Nariman, et al.
Publicado: (2022) -
Long-term administration of immunoglobulin in a patient with anti-SRP immune-mediated necrotizing myopathy
por: Pinheiro, Filipe Oliveira, et al.
Publicado: (2022)